US OKs new Merck drug for rare skin cancer Reuters.uk - By Lisa Richwine. WASHINGTON (Reuters) - Merck & Co Inc. won US approval for a new drug to treat a rare and slow-growing skin cancer, health officials said on Friday.

Mental health no longer the silent issue The Age, Australia - As mental Health Week draws to a close, it is important to note that staying mentally healthy appears to be a continuing concern, defying the boundaries of any ...

Expert Says Dashboard, Cup Holder Are Dirtiest Areas